JK

Jay Kant Shukla

Director Director DIN 08403695
DIN 08403695 First appointment Mar 2019 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2019
Shareholding value Locked Premium profile

About Jay Kant Shukla

Data last updated:

Jay Kant Shukla has 7 years in corporate governance. Formerly with 1 company, such as Eclectus Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08403695
Primary Designation Director
First Appointment 28 Mar 2019
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director28 Mar 20192019Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Eclectus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jay Kant Shukla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jay Kant Shukla

Jay Kant Shukla has 7 years in corporate governance. Formerly with 1 company, such as Eclectus Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Jay Kant Shukla is associated with 0 companies as a director.

Jay Kant Shukla has expertise in General Business.

Jay Kant Shukla has 7 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available